Hyperactivation of the PI3K/Akt/mTOR pathway is common in many cancers, leading to uncontrolled proliferation and resistance to apoptosis, while simultaneously suppressing the tumor-suppressive activity of FOXO transcription factors13,14. This evidence concerns the gene AKT1 and cancer.